Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer. (2017)

First Author: Gilbert DC
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bju.13687

PubMed Identifier: 27753182

Publication URI: http://europepmc.org/abstract/MED/27753182

Type: Journal Article/Review

Volume: 119

Parent Publication: BJU international

Issue: 5

ISSN: 1464-4096